In January 2004 Lux Biotechnology signed an exclusive distribution agreement for the UK and the Republic of Ireland with Prolume for its Nanolight products
Prolume is a biotech company at the cutting edge of bioluminescence research and its Nanolight range offers high quality products with a wide application in different areas of screening and basic research.
In recent years luminescence and fluorescence based techniques have become central in all scientific disciplines from gene expression to food testing and chemical compound analysis.
Lux is dedicated to the development of screening technologies incorporating optoelectronics and incorporating Nanolight complements the company's own technology portfolio.
Nanolight products became available for purchase as of 13 April 2004.
Prolume is a biotechnology company whose core business is based upon newly discovered genes from deep water marine bioluminescent organisms.
This has broad applications for biomedical research, drug discovery, and entertainment.
Prolume is based in Pinetop , Arizona , USA.
